P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL...

por Cordoba, R., Falchi, L., Phillips, T., de Vos, S., Nijland, M., Offner, F., Bykhovski, I., Wu, J., Wang, L., Rana, A., Abrisqueta, P.
Publicado 2022

P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELI...

por Sancho, J.-M., Lopez-Guillermo, A., Abrisqueta, P., Kumar, A., Cordoba, R., Tani, M., Zhao, W., Rappold, E., Langmuir, P., Mims, M.
Publicado 2022

P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSP...

por Wahlin, B. E., Brody, J., Phillips, T., Costello, R., Lugtenburg, P., Cordoba, R., Wang, L., Wu, J., Elliott, B., Abbas, A., Jørgensen, J.
Publicado 2022

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO REC...

por De La Fuente, A., Peñalver, F. J., Herrera, P., Cordoba, R., Martinez Chamorro, C., Olave, M. T., Jarque, I., Navarro, M. B., Estévez, M.
Publicado 2022

P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE

por Clausen, M. R., Offner, F., Belada, D., Brody, J., Linton, K. M., Karimi, Y., Cordoba, R., Snauwaert, S., Abbas, A., Wang, L., Wu, J., Elliott, B., Falchi, L.
Publicado 2022

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CI...

por Hamadani, M., Coleman, M., Boccia, R., Duras, J., Hutchings, M., Zinzani, P. L., Cordoba, R., Oreiro, M. B., Williams, V., Stouffs, M., Langmuir, P., Sancho, J.-M.
Publicado 2022

Competition between Superconductor – Ferromagnetic stray magnetic fields in YBa(2)Cu(3)O(7−x) films pierced with Co nano-rods

por Rouco, V., Córdoba, R., De Teresa, J. M., Rodríguez, L. A., Navau, C., Del-Valle, N., Via, G., Sánchez, A., Monton, C., Kronast, F., Obradors, X., Puig, T., Palau, A.
Publicado 2017

PB2343: MONITORING PHYSICAL ACTIVITY OF OLDER ADULTS WITH HEMATOLOGICAL MALIGNANCIES. THE IMPORTANCE OF CONDUCTING AN INDIVIDUALIZED FOLLOW-UP PROGRAM TO PREVENT FUNCTIONAL IMPAIRM...

por Cotano Abad, L., González de Villaumbrosia, C., Miranda, C., Velasco, A., Salvatierra, M. G., Torras, S., Barrera, R., García, V., Gonzalez, S., Olaya, G., Saenz deTejada, A., Valverde, C., Barba, R., Córdoba, R.
Publicado 2022

P1730: IMPLEMENTATION OF PRO-CTCAE QUESTIONNAIRE IN PROM PROGRAM COLLECTS DIFFERENT ADVERSE EVENTS PROFILE THAN PHYSICIANS AND REDUCE UNSCHEDULED HEALTHCARE IN PATIENTS WITH LYMPHO...

por RAMOS, S., CASTILLO, E., BARRERAS, N., RIESCO, M., HERRERO, A., PASCUAL, A., LOPEZ, A., PEREZ, M. A., MORILLO, D., ASKARI, E., PRIETO, E., LLAMAS, P., BECARES, J., BARRIOCANAL, C., DEL OLMO, M., SHORT, J., ARCOS, J., CORDOBA, R.
Publicado 2022

P1718: A PROSPECTIVE MULTICENTER SURVEY ABOUT THE USE OF NEW TECHOLOGIES AND DIGITAL HEALTH TOOLS IN PATIENTS (PTS) WITH HEMATOLOGICAL MALIGNANCIES

por Lopez-Garcia, A., Diaz-Aizpun, C., Gallego-Diaz, B., Miranda-Castillo, C., Yuste-Platero, M., Beltran-Alvarez, P., Carames-Sanchez, C., Garcia-Foncillas, J., Llamas-Sillero, P., del Olmo Rodriguez, M., Short Apellaniz, J., Arcos Campillo, J., Cordoba, R.
Publicado 2022

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA

por Alonso Alonso, R., Rodríguez, M., Privette Vinnedge, L. M., Serrano, J., Jiménez de las Pozas, Y., G Pedrero, S., Laínez, D., García Raso, A., Alonso Dominguez, J. M., López García, A., Córdoba, R., Piris, M. A., Llamas Sillero, P., Sánchez García, J., Serrano Lopez, J.
Publicado 2022